ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8%
Fri, 24 Aug

ORCHID PHARMA LTD has announced its results for the quarter ended March 2018. Here is a detailed performance review of the same:

ORCHID PHARMA LTD Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-17*
3
Dec-17*
3
Mar-18*
QoQ ChangeYoY Change
Net SalesRs m2,0491,4421,5588.0%-24.0%
Other incomeRs m868414-83.1%-83.5%
TurnoverRs m2,1341,5261,5723.0%-26.4%
ExpensesRs m1,9921,3062,27273.9%14.0%
Gross profitRs m-521136-714-625.0%
DepreciationRs m349335326-2.7%-6.7%
InterestRs m1,2137620-100.0%-100.0%
Profit before taxRs m-1,997-877-1,025
TaxRs m-119-105-101
Profit after taxRs m-1,879-772-924
Gross profit margin%-25.49.4-45.8
Effective tax rate%5.911.99.9
Net profit margin%-88.0-50.6-58.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 24.0% on a year-on-year (YoY) basis. The expenses were up by 14.0% YoY during the same period.
  • The company's operating profit increased by 37.0% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 45.8% in 4QFY18 as against 25.4% in 4QFY17.
  • Depreciation charges and finance costs declined by 6.7% YoY and 100.0% YoY, respectively.
  • Other income declined by 83.5% YoY during the quarter.
  • Net profit for the quarter increased by 50.8% YoY. Net profit margins during the quarter increased from -88.0% in 4QFY17 to -58.8% in 4QFY18.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 8.0% on a quarter-on-quarter (QoQ) basis. The expenses were up by 73.9% QoQ during the same period.
  • The company's operating profit declined by 625.0% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 45.8% in 4QFY18 as against 9.4% in 3QFY17.
  • Net profit for the quarter declined by 19.6% QoQ, while net profit margins declined from -50.6% in 3QFY17 to -58.8% in 4QFY18.

To see how ORCHID PHARMA LTD has performed over the last eight quarters, please visit here.

ORCHID PHARMA LTD Share Price Performance

Over the last one year, ORCHID PHARMA LTD share price has moved up from Rs 20.2 to Rs 7.6, registering a Loss of Rs 12.7 or around 62.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 15,410.4 (down 0.1%). Over the last one year it has moved up from 13,226.3 to 15,410.4, a gain of 2,184 points (up 16.5%).

Overall, the S&P BSE SENSEX is up 21.5% over the year.

Current Valuations

At the current price of Rs 7.6, the price to book value (P/BV) ratio of ORCHID PHARMA LTD stands at 0.2 times.

Equitymaster requests your view! Post a comment on "ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8%". Click here!

  

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 5-YR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS